体重指数对CKD患者肥胖误分类对死亡率的影响
该前瞻性研究纳入326例非透析依赖CKD患者,中位随访4.9年,发现BMI与体脂百分比(BF%)诊断肥胖不一致:BMI定义肥胖27.9%,BF%定义48.8%。BMI定义肥胖与较低死亡风险相关(HR 0.23),而BF%定义肥胖与较高死亡风险相关(HR 2.75),提示BMI误分类可部分解释肥胖悖论。
要点
- BMI诊断肥胖特异性高但敏感性低,易漏诊BF%定义的肥胖。
- BF%定义肥胖者死亡风险升高,而BMI定义肥胖者死亡风险降低。
- 正常BMI但BF%高者(肌少性肥胖)死亡风险显著增高。
核心结论
- BMI与BF%诊断不一致可部分解释CKD患者的肥胖悖论,需正确诊断肥胖以进行风险预测和治疗。
研究设计与样本
- 前瞻性队列研究,纳入326例非透析依赖CKD患者,中位随访4.9年(范围2.9-5.3)。
主要发现
- BMI定义肥胖者占27.9%,BF%定义肥胖者占48.8%。
- BMI≥28 kg/m2检测BF%定义肥胖的敏感性39.6%,特异性83.2%。
- 完全调整模型中,BMI定义肥胖与较低死亡风险相关(HR 0.23;95%CI 0.07-0.71;P=0.011)。
- BF%定义肥胖与较高死亡风险相关(HR 2.75;95%CI 1.28-5.89;P=0.009)。
- 正常BMI但BF%高者(占29.4%)较BMI和BF%均定义肥胖者死亡风险更高(HR 5.11;95%CI 1.43-18.26;P=0.012)。
关键数值与推荐
- 肥胖诊断标准:BMI≥28 kg/m2或BF%>25%(男性)、>35%(女性)。
- BF%和瘦体重使用Body Composition Monitor多频生物阻抗谱设备测定。
临床怎么用
- 在CKD患者中应使用BF%评估肥胖,避免仅依赖BMI导致误分类和风险误判。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Unlike the general population, a higher body mass index (BMI) is associated with greater survival among patients with chronic kidney disease (CKD). This "obesity paradox" may be due to limitations of BMI as a measure of adiposity in CKD. Both BMI and body fat percentage (BF%) are used to classify obesity, but outcomes may vary. Therefore, we investigated the 2 different cutoffs for diagnosing obesity (BMI ≥28 kg/m2 or BF% >25% for men and >35% for women) and the impact on all-cause mortality in CKD. METHODS: A total of 326 patients with non-dialysis-dependent CKD were prospectively followed for a median of 4.9 years (range 2.9-5.3). BF% and lean body mass were determined using the Body Composition Monitor, a novel multifrequency bioimpedance spectroscopy device. Covariates included age, gender, diabetes, cardiovascular disease, estimated glomerular filtration rate, proteinuria, and high-sensitivity C-reactive protein. RESULTS: Per the BMI definition, 27.9% of patients were obese. However, 48.8% of patients were obese according to the BF% definition. A BMI ≥28 kg/m2 had a moderately high specificity of 83.2% but a low sensitivity of 39.6% for detecting BF%-defined obesity. In the fully adjusted models containing both BMI and BF%, obesity defined by BMI was associated with a significantly lower risk of death (hazard ratio [HR]: 0.23; 95% CI: 0.07-0.71; P = 0.011), whereas the result was reversed when obesity was defined by BF% (HR: 2.75; 95% CI: 1.28-5.89; P = 0.009). When patients were classified into 4 distinct groups based on both the BMI and BF% cutoffs for obesity, a considerable proportion of patients (29.4%) had excess body fat in the context of a normal BMI. These patients were more likely to have lower lean body mass (i.e., sarcopenic obesity) and had higher mortality compared with patients with obesity defined by both BMI and BF% (HR: 5.11; 95% CI: 1.43-18.26; P = 0.012). CONCLUSION: Diagnostic discordance between BMI and BF% may partly explain the obesity paradox. Proper diagnosis of obesity in patients with CKD is required for both risk prediction and treatment.
引用
- Lin TY, Lim PS, Hung SC, et al. Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With CKD. Kidney Int Rep. 2017. PMID: 29725649. doi:10.1016/j.ekir.2017.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。